Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes

Fundamental and Clinical Pharmacology

Volumn 25, Issue 1, 2011, Pages 99-103

  Le Vee, Marc ^a   Jouan, Elodie ^a   Moreau, Amélie ^a   Fardel, Olivier ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Cytokine; Drug transporter; Hepatocyte; Inflammation; Interferon ; Pharmacokinetics

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; TAUROCHOLIC ACID;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIVER CELL; LIVER SINUSOID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADULT; CELLS, CULTURED; DOWN-REGULATION; HEPATOCYTES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; MEMBRANE TRANSPORT PROTEINS; RNA, MESSENGER; VIRUS DISEASES;

EID: 78650926991     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00822.x     Document Type: Article

References (20)

1. Renton K.W. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol. Ther. (2001) 92 147-163.
2. Slaviero K.A., Clarke S.J., Rivory L.P. Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. (2003) 4 224-232.
3. Morgan E.T., Goralski K.B., Piquette-Miller M. et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab. Dispos. (2008) 36 205-216.
4. Bleau A.M., Maurel P., Pichette V., Leblond F., du Souich P. Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha and interferon-gamma released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes. Eur. J. Pharmacol. (2003) 473 197-206.
5. Abdel-Razzak Z., Loyer P., Fautrel A. et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. (1993) 44 707-715.
6. Aitken A.E., Morgan E.T. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab. Dispos. (2007) 35 1687-1693.
7. Le Vee M., Gripon P., Stieger B., Fardel O. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab. Dispos. (2008) 36 217-222.
8. Le Vee M., Lecureur V., Stieger B., Fardel O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab. Dispos. (2009) 37 685-693.
9. Petrovic V., Teng S., Piquette-Miller M. Regulation of drug transporters during infection and inflammation. Mol. Interv. (2007) 7 99-111.
10. Funk C. The role of hepatic transporters in drug elimination. Expert Opin. Drug Metab. Toxicol. (2008) 4 363-379.
11. Fardel O., Le Vee M. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opin. Drug Metab. Toxicol. (2009) 5 1469-1481.
12. Gomez-Lechon M.J., Donato M.T., Castell J.V., Jover R. Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr. Drug Metab. (2004) 5 443-462.
13. Jigorel E., Le Vee M., Boursier-Neyret C., Bertrand M., Fardel O. Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug Metab. Dispos. (2005) 33 1418-1422.
14. Le Vee M., Lecureur V., Moreau A., Stieger B., Fardel O. Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes. Drug Metab. Dispos. (2009) 37 2228-2235.
15. Jigorel E., Le Vee M., Boursier-Neyret C., Parmentier Y., Fardel O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. (2006) 34 1756-1763.
16. Muhlbauer M., Fleck M., Schutz C. et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J. Hepatol. (2006) 45 520-528.
17. Lanford R.E., Guerra B., Lee H., Chavez D., Brasky K.M., Bigger C.B. Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology (2006) 43 961-972.
18. Moseley R.H. Sepsis-associated cholestasis. Gastroenterology (1997) 112 302-306.
19. Liptrott N.J., Penny M., Bray P.G. et al. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br. J. Pharmacol. (2009) 156 497-508.
20. Belliard A.M., Lacour B., Farinotti R., Leroy C. Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J. Pharm. Sci. (2004) 93 1524-1536.